Tzana

India
Pharmaceutical manufacturing and distribution of quality medicines in India.

About Tzana

Tzana is a Healthcare company based in India. Pharmaceutical manufacturing and distribution of quality medicines in India. Its Indian entity Tzana Pharmaceuticals Private Limited reported revenue of β‚Ή41 Lakh. Tzana offers products and services including Pediatrics Medicines and Gynaecology Medicines. Its focus areas include Pharmaceuticals, Medicine Manufacturing, Formulations and Medical Distribution.

Company details

Quality medicines are manufactured and supplied by Tzana Pharmaceuticals to eradicate diseases and treat illnesses across all life stages, providing significant societal benefits in terms of quality of life and economic value. Access to these medicines is ensured even in remote areas, with a focus on balanced formulations and strict ethical practices aligned with global health objectives. The companys commitment to long-term risk-free options and ethical standards is emphasized, supporting international community goals without compromising on quality.

  • Headquarters India
  • Sectors
    Healthcare
  • Legal Name Tzana Pharmaceuticals Pvt Ltd
  • Date of Incorporation 07 Jun, 2017
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹41 Lakh

    FY 2025 · +74% YoY

  • Net Loss
    -₹13.9 Lakh

    FY 2025 · -34% margin

  • EBITDA
    -₹13.9 Lakh

    FY 2025 · -34% margin

Products & Services of Tzana

Tzana offers a comprehensive portfolio of products and services, including Pediatrics Medicines and Gynaecology Medicines.

Pediatrics Medicines
Pharmaceuticals

Medicines for pediatric care are manufactured and supplied by Tzana Pharmaceuticals to treat illnesses at various life stages.

Gynaecology Medicines
Pharmaceuticals

Medicines for gynaecology are developed and distributed by Tzana Pharmaceuticals to improve health outcomes in specific disease areas.

Board of directors of Tzana Pharmaceuticals Private Limited (Tzana)

Tzana Pharmaceuticals Private Limited is the primary company behind Tzana. The board of Tzana Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Abdulbijur Vallarkodath, appointed in 2017.

DirectorDesignationAppointedTenureEntity
Abdulbijur Vallarkodath
DIN 03382134
Director07 Jun 20179 yrs 4 moTzana Pharmaceuticals Private Limited
Chundanveetil Aboobacker Abdul Najeeb
DIN 07820912
Director07 Jun 20179 yrs 4 moTzana Pharmaceuticals Private Limited
Farzana Bijur Abdul
DIN 06533803
Additional Director12 Jan 20188 yrs 9 moTzana Pharmaceuticals Private Limited

Financials of Tzana

Figures of Tzana Pharmaceuticals Private Limited, the primary company behind Tzana, for FY 2025. Revenue was ₹41 Lakh (+74% year on year). Net loss was -₹13.9 Lakh (-34% margin). EBITDA was -₹13.9 Lakh (-34% margin). Revenue has grown at a compounded annual rate of +1% over three years and +3% over five years.

  • ₹41 LakhRevenue · FY 2025 · +74% YoY
  • -₹13.9 LakhNet loss · -34% margin
  • -₹13.9 LakhEBITDA · -34% margin
  • ₹1 LakhPaid-up capital
  • +1%Revenue CAGR, 3 years
  • +3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Tzana Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Tzana

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Tzana

Tzana is headquartered in India.

The primary company behind Tzana, Tzana Pharmaceuticals Private Limited, reported revenue of β‚Ή41 Lakh for FY 2025, up 74% year on year.

Quality medicines are manufactured and supplied by Tzana Pharmaceuticals to eradicate diseases and treat illnesses across all life stages, providing significant societal benefits in terms of quality of life and economic value. Access to these medicines is ensured even in remote areas, with a focus on balanced formulations and strict ethical practices aligned with global health objectives. The companys commitment to long-term risk-free options and ethical standards is emphasized, supporting international community goals without compromising on quality.

Tzana offers Pediatrics Medicines and Gynaecology Medicines.

Tzana operates through Tzana Pharmaceuticals Private Limited.

The legal entities of Tzana currently have 3 directors, including Abdulbijur Vallarkodath, Farzana Bijur Abdul, Chundanveetil Aboobacker Abdul Najeeb.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available